Epilepsy Research
Volume 27, Issue 3 , Pages 205-213, June 1997

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy1

  • Marilisa M Guerreiro

      Affiliations

    • Neurological Department, Faculty of Medicine, UNICAMP, Campinas, Brazil
    • ,
  • Ulf Vigonius

      Affiliations

    • Novartis Sverige AB, Västra Frölunda, Sweden
    • Corresponding Author InformationCorresponding author. Present address: Novartis Sverige AB, P.O. Box 1150, S-183 11 Taeby, Sweden.
    • ,
  • Harald Pohlmann

      Affiliations

    • Novartis Pharma AG, Basel, Switzerland
    • ,
  • Maria Luiza G de Manreza

      Affiliations

    • Neurological Department, Hospital Das Clinicas, Sao Paulo, Brazil
    • ,
  • Natalio Fejerman

      Affiliations

    • Neurological Department, Children Hospital `Professor Dr Juan P. Garrahan', Buenos Aires, Argentina
    • ,
  • Sergio A Antoniuk

      Affiliations

    • Neurological Department, Hospital Nossa Senhora das Gracas, Curitiba, Brazil
    • ,
  • Alan Moore

      Affiliations

    • Novartis Pharma AG, Basel, Switzerland

Received 26 March 1997; received in revised form 11 April 1997; accepted 13 April 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-1211(97)00025-9

Epilepsy Research
Volume 27, Issue 3 , Pages 205-213, June 1997

Article Tools

* Image Usage & Resolution